A study comparing corneal biomechanical properties measured by Ocular Response Analyzer (ORA) in patients before and after intravitreal ranibizumab injection
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2021 New trial record